Effects of Prophylactic Lidocaine in Suspected Acute Myocardial Infarction: An Overview of Results From the Randomized, Controlled Trials | JAMA | JAMA Network
[Skip to Navigation]
Article
October 7, 1988

Effects of Prophylactic Lidocaine in Suspected Acute Myocardial Infarction: An Overview of Results From the Randomized, Controlled Trials

Author Affiliations

From the International Studies of Infarct Survival (ISIS) Trials Office, Clinical Trial Service Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, University of Oxford, England (Drs MacMahon and Collins and Mr Peto); the Clinical Trials Branch, National Heart, Lung, and Blood Institute, Bethesda, Md (Drs MacMahon and Yusuf); the Department of Cardiovascular Medicine, John Radcliffe Hospital, Oxford, United Kingdom (Dr Collins); and the Department of Cardiology, Academic Medical Center, University of Amsterdam, the Netherlands (Dr Koster).

From the International Studies of Infarct Survival (ISIS) Trials Office, Clinical Trial Service Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, University of Oxford, England (Drs MacMahon and Collins and Mr Peto); the Clinical Trials Branch, National Heart, Lung, and Blood Institute, Bethesda, Md (Drs MacMahon and Yusuf); the Department of Cardiovascular Medicine, John Radcliffe Hospital, Oxford, United Kingdom (Dr Collins); and the Department of Cardiology, Academic Medical Center, University of Amsterdam, the Netherlands (Dr Koster).

JAMA. 1988;260(13):1910-1916. doi:10.1001/jama.1988.03410130118036
Abstract

The effects of prophylactic lidocaine hydrochloride on early ventricular fibrillation and death in patients with suspected acute myocardial infarction were investigated in an overview of 14 randomized trials. During follow-up intervals of one to four hours in the trials of intramuscular lidocaine infusion (6961 patients) and 24 to 48 hours in the trials of intravenous lidocaine injection (2194 patients), a total of 103 cases of ventricular fibrillation and 137 deaths were recorded. Overall, allocation to lidocaine was associated with a reduction in the odds of ventricular fibrillation of about one third, with a 95% confidence interval that ranged from a 3% to a 56% reduction. There was no evidence of any beneficial effect on early mortality; indeed, the odds of early death were about one third greater among patients allocated lidocaine, though this difference was not statistically significant (95% confidence interval, 2% reduction to 95% increase). Because of the small numbers of reported events, the short follow-up periods, and the unavailability of data for some specific causes of death, even an overview of all the trial results does not provide good evidence as to whether prophylactic lidocaine is likely to be helpful or harmful. To answer this question reliably, future trials will need to involve large numbers of patients and prolonged follow-up.

(JAMA 1988;260:1910-1916)

References
1.
Dalen JE, Goldberg RJ, Gore JM, et al:  Therapeutic interventions in acute myocardial infarction. Survey of the ACCP Section in Clinical Cardiology .  Chest 1984;2:257-262.Crossref
2.
Hlatky MA, Cotugno HE, Mark DB, et al:  Trends in physician management of uncomplicated acute myocardial infarction, 1970 to 1987 .  Am J Cardiol 1988;61:515-518.Crossref
3.
Gianelly R, von der Groeben JO, Spivack AP, et al:  Effect of lidocaine on ventricular arrhythmias in patients with coronary heart disease .  N Engl J Med 1967;277:1215-1219.Crossref
4.
Lown B, Vassaux C:  Lidocaine in acute myocardial infarction .  Am Heart J 1968;76:586-587.Crossref
5.
De Silva RA, Hennekens CH, Lown B, et al:  Lignocaine prophylaxis in acute myocardial infarction: An evaluation of randomised trials .  Lancet 1981;2:855-858.Crossref
6.
Kertes P, Hunt D:  Prophylaxis of primary ventricular fibrillation in acute myocardial infarction: The case against lignocaine .  Br Heart J 1984; 52:241-247.Crossref
7.
Furberg CD:  Effect of antiarrhythmic drugs on mortality after myocardial infarction .  Am J Cardiol 1983;52:32C-36C.Crossref
8.
Kostuk WJ, Beanlands DS:  Prophylactic lidocaine in acute myocardial infarction .  Circulation 1969;39( (suppl III) ):III-125.
9.
Bennett MA, Wilner JM, Pentecost BL:  Controlled trial of lignocaine in prophylaxis of ventricular arrhythmias complicating myocardial infarction .  Lancet 1970;2:909-911.Crossref
10.
Baker IA, Collins JV, Evans TR:  Prophylaxis of ventricular dysrhythmias following acute myocardial infarction: A double-blind trial of continuous intravenous infusion of lignocaine .  Guys Hosp Rep 1971;120:1-7.
11.
Chopra MP, Thadani U, Portal RW, et al:  Lignocaine therapy for ventricular ectopic activity after acute myocardial infarction: A double-blind trial .  Br Med J 1971;3:668-670.Crossref
12.
Pitt A, Lipp H, Anderson ST:  Lignocaine given prophylactically to patients with acute myocardial infarction .  Lancet 1971;1:612-616.Crossref
13.
Darby S, Bennett MA, Cruickshank JC, et al:  Trial of combined intramuscular and intravenous lignocaine in prophylaxis of ventricular tachyarrhythmias .  Lancet 1972;1:817-819.Crossref
14.
O'Brien KP, Taylor PM, Croxson RS:  Prophylactic lignocaine in hospitalized patients with acute myocardial infarction .  Med J Aust Suppl 1973;2:36-37.
15.
Lie KI, Wellens HJ, van Capelle FJ, et al:  Lidocaine in the prevention of primary ventricular fibrillation: A double-blind, randomized study of 212 consecutive patients .  N Engl J Med 1974; 291:1325-1326.Crossref
16.
Wyse DG, Kellen J, Rademaker AW:  Prophylactic versus selective lidocaine for early ventricular arrhythmias of myocardial infarction .  J Am Coll Cardiol 1988;12:507-513.Crossref
17.
Sandler G, Dey N, Amonkar J:  Prophylactic intramuscular lidocaine in myocardial infarction .  Curr Ther Res 1976;20:563-573.
18.
Singh JB, Kocot SL:  A controlled trial of intramuscular lidocaine in the prevention of premature ventricular contractions associated with acute myocardial infarction .  Am Heart J 1976;91:430-436.Crossref
19.
Lie KI, Liem KL, Louridtz WJ, et al:  Efficacy of lidocaine in preventing primary ventricular fibrillation within one hour after a 300 mg intramuscular injection .  Am J Cardiol 1978;42:486-488.Crossref
20.
Dunn HM, McComb JM, Kinney CD, et al:  Prophylactic lidocaine in the early phase of suspected myocardial infarction .  Am Heart J 1985;100:353-362.Crossref
21.
Koster RW, Dunning AJ:  Intramuscular lidocaine for prevention of lethal arrhythmias in the prehospitalization phase of acute myocardial infarction . N Engl J Med 1985;313:1105-1110.Crossref
22.
Yusuf S, Simon R, Ellenberg S (eds):  Methodologic issues in overviews of randomized clinical trials .  Stat Med 1987;6:217-409.Crossref
23.
Sachs HS, Berrier J, Reitman D, et al:  Metaanalyses of randomized controlled trials .  N Engl J Med 1987;316:450-455.Crossref
24.
Peto R:  Why do we need systematic overviews of randomized trials?  Stat Med 1987;6:233-240.Crossref
25.
Collins R, Gray R, Godwin J, et al:  Avoidance of large biases and large random errors in the assessment of moderate treatment effects: The need for systematic overviews .  Stat Med 1987;6:245-250.Crossref
26.
Valentine PA, Frew JL, Mashford ML, et al:  Lidocaine in the prevention of sudden death in the pre-hospital phase of acute infarction: A doubleblind study .  N Engl J Med 1974;291:1327-1330.Crossref
27.
Mogensen L:  Ventricular tachyarrhythmias and lignocaine prophylaxis in acute myocardial infarction: A clinical and therapeutic study .  Acta Med Scand Suppl 1970;513( (suppl) ):1-80.
28.
Bleifeld W, Merx W, Heinrich KW, et al:  Controlled trial of prophylactic treatment with lidocaine in acute myocardial infarction .  Eur J Clin Pharmacol 1973;6:119-126.Crossref
29.
Church G, Biern R:  Prophylactic lidocaine in acute myocardial infarction .  Circulation 1972;45-46( (suppl II) ):II-139.
30.
Yusuf S, Peto R, Lewis J, et al:  Beta blockade during and after myocardial infarction: An overview of the randomized trials .  Prog Cardiovasc Dis 1985;27:335-371.Crossref
31.
Antiplatelet Trialists' Collaboration:  Secondary prevention of vascular disease by prolonged antiplatelet treatment .  Br Med J 1988;296:320-331.Crossref
32.
Volpi A, Maggioni A, Frazia MF, et al:  Inhospital prognosis of patients with acute myocardial infarction complicated by primary ventricular fibrillation .  N Engl JMed 1987;317:257-261.Crossref
×